Quantamental Technologies LLC Eagle Pharmaceuticals, Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $96,526 - $114,278	-1,777 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$53.25 - $59.98 $27,796 - $31,309	-522 Reduced 22.71%	1,777 $101,000
Q2 2019 Aug 12, 2019	BUY	$46.61 - $58.45 $34,631 - $43,428	743 Added 47.75%	2,299 $128,000
Q1 2019 Apr 29, 2019	BUY	$38.66 - $51.82 $60,154 - $80,631	1,556 New	1,556 $79,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.